Next October 25th at 8:15am Belén Bornstein, Deputy Director of Evaluation and Promotion of Research at the Institute of Health Carlos III, will give an extraordinary session entitled “Present and future of AES in the context of Translational Research in Biomedicine”.
The conference will take place in the Assembly Hall of Tower B at Marqués de Valdecilla University Hospital and at the end there will a cafe where the Assistant Director will talk to all the interested assistants.
Belén Bornstein (Madrid, 1959) gained a degree in Medicine and Surgery from the Universidad Complutense de Madrid in 1983 and a PhD from the same University in 1990.
Her specialty in Clinical Biochemistry was in the Hospital 12 de Octubre and her work as a specialist was developed in the Severo Ochoa Hospital in Leganés and Puerta de Hierro University Hospital in Madrid, in which she joined in 2005. As a complement to her training she did two stays in international centers as the Carlo Besta Institute in Milan and Columbia University in New York.
She has a long experience in the study of mitochondrial diseases, which began in 1990 with the biochemical study of mitochondrial myopathies in the laboratory of metabolic diseases of the Hospital 12 de Octubre in Madrid.
Scientific evaluation has been another of her professional activities. She was a member of the Technical Evaluation Committee of the human resources programs and of the Technical Commission for Infrastructure Evaluation of the Health Research Fund, evaluator of research projects of the Health Research Fund and at the National Evaluation and Prospective Agency (ANEP).
It is part of the mitochondrial pathology program of the CIBER of rare diseases (CIBERER) since its creation. In 2008 she was appointed head of the molecular genetics unit at Madrid's Puerta de Hierro University Hospital. The genetic study of familial heart disease is one of its primordial areas. She collaborated in the accreditation, which was obtained in 2014, of the reference unit (CESUR) of the Family Cardiopathies in the Cardiology Service at the same hospital.
In 2010 she assumed the leadership of the Group of Mitochondria and Cardiopathies at the Research Institute of Puerta de Hierro University Hospital (Idiphim); in January of 2015 she joined ISCIII as Director of Institutional Relations and later as Deputy Director of Evaluation and Promotion of Research, which she currently holds.
